Ballew Advisors, Inc Haleon PLC Transaction History
Ballew Advisors, Inc
- $142 Million
- Q1 2024
A detailed history of Ballew Advisors, Inc transactions in Haleon PLC stock. As of the latest transaction made, Ballew Advisors, Inc holds 12,597 shares of HLN stock, worth $109,971. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,597
Previous 12,597
-0.0%
Holding current value
$109,971
Previous $103,000
2.91%
% of portfolio
0.07%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding HLN
# of Institutions
639Shares Held
425MCall Options Held
82KPut Options Held
27.3K-
Dodge & Cox San Francisco, CA177MShares$1.54 Billion0.92% of portfolio
-
Clearbridge Investments, LLC New York, NY38.4MShares$336 Million0.27% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa14.4MShares$126 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA13.4MShares$117 Million0.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il13.2MShares$115 Million0.02% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $40.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...